Next Article in Journal
Maternal High-Fat Diet Controls Offspring Kidney Health and Disease
Next Article in Special Issue
Maternal Intake of Vitamin D Supplements during Pregnancy and Pubertal Timing in Children: A Population-Based Follow-Up Study
Previous Article in Journal
Protective Effect of Citrus Medica limonum Essential Oil against Escherichia coli K99-Induced Intestinal Barrier Injury in Mice
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

The Association between Serum Vitamin D Levels and Urinary Tract Infection Risk in Children: A Systematic Review and Meta-Analysis

1
Department of Pediatrics, West China Second University Hospital, Sichuan University, Chengdu 610041, China
2
Key Laboratory of Birth Defects and Related Diseases of Women and Children (Sichuan University), Ministry of Education, NHC Key Laboratory of Chronobiology, Sichuan University, Chengdu 610041, China
*
Author to whom correspondence should be addressed.
Nutrients 2023, 15(12), 2690; https://doi.org/10.3390/nu15122690
Submission received: 14 May 2023 / Revised: 3 June 2023 / Accepted: 7 June 2023 / Published: 9 June 2023
(This article belongs to the Special Issue Vitamin D in the Healthy Development and Disease of Children)

Abstract

:
The association between serum vitamin D levels and urinary tract infection (UTI) in children is unclear. We undertook a systematic review and meta-analysis to evaluate the relationships between different vitamin D levels and the likelihood of UTI in children. Online databases, including Web of Science, PubMed, Embase, and Cochrane Library, were searched up to 6 February 2023 for studies based on the inclusion criteria. Weighted mean difference (WMD) and Odds Ratios (ORs), along with their 95% confidence intervals (CI), were calculated, and the random-effects model was used for analysis. Twelve case–control studies and one cross-sectional study (839 children with UTI and 929 controls) were included. We found that children with UTI had lower levels of serum vitamin D than healthy controls (WMD: −7.730, 95% CI: −11.57, −3.89; p < 0.001). Low vitamin D levels were significantly associated with UTI in children (OR: 2.80; 95% CI: 1.55, 5.05; p = 0.001). The likelihood of children having a UTI significantly increased when their serum vitamin D level was less than 20 ng/mL (OR: 5.49, 95% CI: 1.12, 27.04; p = 0.036). Therefore, vitamin D level, especially when less than 20 ng/mL, is a risk factor in UTI.

1. Introduction

Urinary tract infection (UTI), including pyelonephritis and cystitis, is a common bacterial infection in children of all ages, with a prevalence ranging from 1.8% to 7.5% [1]. UTI is mainly caused by Escherichia coli (70–90%), and the other common pathogenic bacteria include Klebsiella, Proteus, Enterococcus, and Enterobacter species [2,3]. If not treated promptly, UTI may lead to renal scarring, and even severe renal disease [4]. Tc 99–labeled dimercaptosuccinic acid scanning revealed renal defects in 85% of children with febrile UTI, and permanent renal scarring occurred in 10–40% of them [5]. Therefore, timely treatment of UTI and early identification of the risk of renal damage after UTI are important, but it would be preferable if UTI could be prevented.
Vitamin D receptor (VDR) and vitamin D-activating enzyme (1α-hydroxylase) are found in many types of immune cells. Serum 25(OH)D is activated and converted into 1,25(OH)2D, the active form of vitamin D, in immune cells. 1,25(OH)2D binds to the VDR to regulate DNA transcription, stimulate the expression of antimicrobial peptides, and enhance innate immune responses [6,7,8].
Following the discovery of the VDR, increasing research has been conducted on the role of vitamin D in regulating the immune system [9,10]. Many studies have shown that vitamin D plays a protective role in innate and adaptive immunity [11,12,13]. Vitamin D deficiency has been considered to be associated with infections, mostly in adult patients but also in pediatrics, including with the recent COVID-19 pandemic and UTI [14,15,16,17,18,19,20]. Vitamin D has been found to reduce the inflammatory response by reducing interferon-γ production in the immune system, and up-regulating antimicrobial peptides in the bladder during Escherichia coli infections, thereby reducing urethral damage [17,21].
Many clinical studies have reported a relationship between serum vitamin D levels and UTI in children, demonstrating that vitamin D insufficiency or deficiency may be a risk factor for UTI [22,23,24,25,26,27,28,29,30,31,32]. Vitamin D supplementation may prevent UTI [33]. However, some studies have shown no significant relationship between serum vitamin D levels and UTI in childhood, and vitamin D supplementation may even increase the risk of infection [34,35,36]. The relationship between vitamin D levels and UTI in children is controversial; a systematic review and meta-analysis has been conducted, but the included studies were limited [37]. Our aim was to update the analysis and to evaluate the relationships between different vitamin D levels and the likelihood of UTI in children.

2. Materials and Methods

The systematic review and meta-analysis were conducted based on the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA), which was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (no. CRD42023398469).

2.1. Search Strategy

The literature search was independently conducted by two researchers using the Web of Science, PubMed, Embase, and Cochrane Library databases for articles published up to 6 February 2023. In our search, we used a combination of mesh terms and their free forms.

2.2. Selection Criteria

The inclusion criteria were based on PICOS as follows: population (P), children (aged < 18 y); intervention/exposure (I), serum vitamin D levels; comparison (C), vitamin D sufficiency; outcome (O), UTI; and type of study (S), cohort studies/case–control studies/cross-sectional studies. The exclusion criteria were non-English articles, repeatedly published articles, articles with incomplete data, and those without control groups. Based on the inclusion and exclusion criteria, the publications were reviewed and screened independently by two authors, who sought help from a third author to resolve any disagreements.

2.3. Data Extraction

The following information was collected from the available articles: title of the study; first author’s name; publication year; study design; research location (country); sample size; participants’ age; the timing of serum vitamin D level evaluation (before, during, or after onset of UTI); laboratory test methods for serum 25(OH) D levels (including chemiluminescent immunoassay, ELISA, radioimmunoassays, liquid chromatography, and enzyme immunoassays); definition of vitamin D deficiency, insufficiency, or sufficiency (The Endocrine Society guidelines defined serum vitamin D levels below 20 ng/mL as deficient, 20 to 30 ng/mL as insufficient, and above 30 ng/mL as sufficient [38]); mean ± standard deviation (SD) of serum vitamin D levels in children with UTI and controls; the frequency of children with vitamin D deficiency, insufficiency, or sufficiency in both groups with or without UTI; and effect estimation (e.g., Odds Ratio [OR], Relative Risk [RR], or adjusted OR/RR) for UTI in children with vitamin D deficiency or insufficiency compared with vitamin D sufficient children. Two authors screened the data independently and sought help from a third author to resolve any disagreements.

2.4. Quality Assessment

The quality of the included studies was evaluated independently by two authors using the Newcastle-Ottawa Scale (NOS). This scale assesses three major aspects: selection (four items), comparability (one item), and exposure or outcome (three items). Each study had a maximum of one star per item for “selection” and “exposure or outcome”, but a maximum of two stars per item for “comparability”. Therefore, the highest NOS score in the present study was 9. In this study, scores of 0–3, 4–6, and 7–9 were considered low, moderate, and high quality, respectively.

2.5. Statistical Analysis

The weighted mean difference (WMD) and 95% confidence interval (CI) were used to assess serum vitamin D levels in children with UTI compared with controls. If the concentration of serum vitamin D was presented in nmol/L, it was converted to ng/mL using the SI units Conversion Calculator (https://unitslab.com/node/84 (accessed on 11 February 2023)).
Several studies have reported the frequency of children with deficient, insufficient, or sufficient vitamin D in UTI and non-UTI groups. In addition, some studies reported adjusted OR and 95% CI. Therefore, we conducted a meta-analysis of studies with data on the frequency and adjusted ORs.
A random-effects model was used for analysis. We quantified the statistical heterogeneity between studies using the chi-square test and the I2 statistics. When I2 ≥ 50%, it was considered to indicate substantial heterogeneity.
Subgroup analyses based on different continents, research quality, and methods of serum vitamin D measurement were conducted to explore the possible sources of heterogeneity between studies. Subgroup analyses were also performed based on sex and vitamin D levels. A funnel plot was constructed to intuitively reflect publication bias. Additionally, the Egger’s test was used to quantitatively analyze publication bias. To evaluate the robustness of the results, sensitivity analysis was conducted using a one-by-one elimination method. Next, trim-and-fill funnel plots were constructed to confirm the stability of the results. All statistical analyses were performed using STATA15.1. p < 0.05 was considered as statistically significant.

3. Results

3.1. Literature Search

Our search identified 1693 publications. Thirty ongoing trials, identified in the Cochrane Library, were excluded. After automatic reduction and manual screening of the publication year and title, 351 duplicates were excluded. A further 1291 articles were excluded after screening titles and abstracts. Eight studies were excluded after full-text screening. Finally, 13 studies met the eligibility criteria and were included in this systematic review and meta-analysis (Figure 1).

3.2. Characteristics and Quality Assessment of the Included Studies

Twelve case–control studies and one cross-sectional study were included, reporting on 839 children with UTI and 929 controls, aged 3 months to 12 years. Five studies were conducted in Iran [23,27,28,34,35], three in Turkey [22,25,39], and one each in China [33], South India [24], Romania [30], Egypt [29], and Sweden [26]. Serum 25(OH)D or 25(OH)D3, as markers for vitamin D levels, were measured using chemiluminescent immunoassay [24,25,26,27,30], ELISA [22,23,28,39], radioimmunoassays [33,35], liquid chromatography [34], and enzyme immunoassays [29]. Serum vitamin D levels were evaluated after the patients were diagnosed with a UTI while hospitalized [22,23,24,25,26,27,28,29,30,33,34,35,39]. Different criteria were used to define deficient, insufficient, and sufficient levels of serum vitamin D. For example, several studies defined vitamin D deficiency as less than 20 ng/mL [23,24,25,26,27,28,30,33,35,39]. However, two studies defined it as less than 10 ng/mL or 12 ng/mL [22,29], whereas another study did not define it [34]. Logistic regression analysis was used in some studies to adjust for gender, age, body weight, feeding style, and sunshine duration as major confounding factors [24,28,33]. The other two studies adjusted for white blood cell count and levels of C-reactive protein as confounding variables [25,29]. However, other studies did not calculate OR or adjusted OR (Table 1).
NOS scores of the studies ranged from five to eight. Two studies were considered moderate quality, whereas the others were high quality (Table 1).

3.3. Meta-Analyses

3.3.1. Meta-Analysis of Serum Vitamin D Levels

Overall, 11 of the included studies reported mean ± SD in serum vitamin D levels in children with or without UTI. The meta-analysis showed that serum vitamin D level was 7.730 ng/mL lower in children with UTI than that in controls (95% CI: −11.57, −3.89 ng/mL; p < 0.001). However, significant heterogeneity was observed among the studies (p < 0.001; I2 = 96.2%) (Figure 2).
To explore the possible sources of heterogeneity, a subgroup analysis was performed according to factors that might influence the results. The results of subgroup analysis based on children from different regions showed significantly lower levels of vitamin D in children from Asia with UTI [24,33] (WMD: −8.68, 95% CI: −10.79, −6.56; p < 0.001; I2 = 0.0%). However, there were no significant differences in vitamin D levels in children with or without UTI from Europe [26,30] (WMD: −17.22, 95% CI: −35.65, 1.20; p = 0.067; I2 = 94.0%) or the Middle East [22,23,25,29,34,35,39] (WMD: −5.17, 95% CI: −10.41, 0.06; p = 0.053; I2 = 97.5%) (Figure S1A).
Based on the quality of the included studies, the subgroup analysis showed that the serum vitamin D levels in children with UTI were significantly lower in middle quality studies compared with those of the controls [26,39] (WMD: −6.79, 95% CI: −10.07, −3.50; p < 0.001; I2 = 0) and high quality studies [22,23,24,25,29,30,33,34,35] (WMD: −7.99, 95% CI: −12.40, −3.59; p < 0.001; I2 = 96.9%) (Figure S1B).
Subgroup analysis based on different methods of measuring vitamin D levels revealed that the difference was significant in studies using a chemiluminescence immunoassay [24,25,26,30] (WMD: −13.89, 95% CI: −20.04, −7.75; p < 0.001; I2 = 92.5%). However, there was no significant difference in studies using ELISA [22,23,39] (WMD: −2.74, 95% CI: −10.11, 4.64; p = 0.46; I2 = 91.0%) or radioimmunoassay [33,35] (WMD: −6.51, 95% CI: −15.02, 2.00; p = 0.13; I2 = 59.2%) (Figure S1C).
Sensitivity analyses were used to determine whether the heterogeneity originated from one or multiple studies. Heterogeneity was acceptable when four studies were eliminated [23,25,30,34] (p = 0.252, I2 = 23.3%). There was no significant heterogeneity (p = 0.494, I2 = 0.0%) when five studies were excluded [23,25,29,30,34]. When the above four or five studies were removed, the differences in vitamin D levels between the UTI group and controls remained significant (WMD: −6.92, 95% CI: −8.17, −5.67; p < 0.001; WMD: −7.81, 95% CI: −9.42, −6.20; p < 0.001).
Sensitivity analyses demonstrated that the effect value remained significant after removing each study.
Slight asymmetry was observed in the funnel plots. However, the difference was still significant in the trim-and-fill analysis (WMD: −10.41, 95% CI: −14.43, −6.39; p < 0.001) (Figure 3). Moreover, Egger’s test revealed no significant publication bias (p = 0.918).

3.3.2. Meta-Analysis of ORs

From the nine studies, we derived the frequency of sufficient and low vitamin D levels (including insufficiency and deficiency) in children with UTI and controls. The analysis of ORs demonstrated a significant association between UTI and low vitamin D levels (OR: 2.80; 95% CI: 1.55, 5.06; p = 0.001). Heterogeneity was significant between the studies (p < 0.001; I2 = 77.5%) (Figure 4).
We carried out a subgroup analysis based on different levels of serum vitamin D, and the results showed that children were significantly more likely to develop UTI when their serum vitamin D levels were less than 20 ng/mL (OR: 5.49, 95% CI: 1.12, 27.04; p = 0.036; I2 = 87.7%). However, there was not a significant association between vitamin D levels and the likelihood of UTI when serum vitamin D levels were between 20 and 30 ng/mL (OR: 1.72, 95% CI: 0.82, 3.61; p = 0.150; I2 = 70.5%) (Figure 5).
We also carried out a subgroup analysis based on sex for two studies that stratified by sex [22,28]. The results showed a significant association between low vitamin D levels and the likelihood of UTI in female children (OR: 5.00, 95% CI: 2.19, 11.39; p < 0.001; I2 = 0.0%), but not in male children (OR: 1.43, 95% CI: 0.37, 5.55; p = 0.604; I2 = 0.0%) (Figure S2).
The results of the subgroup analysis based on children from different regions showed a significant association between low vitamin D levels and the likelihood of UTI in the studies conducted in Asia [24,33] (OR: 2.73, 95% CI: 1.80, 4.13; p < 0.001; I2 = 0.0%) and in Europe [30] (OR: 13.67, 95% CI: 4.90, 38.15; p < 0.001; I2 = 0.0%). However, there was not a significant association for the studies conducted in the Middle East [22,23,27,28,29,34] (OR: 2.18, 95% CI: 0.92, 5.14; p = 0.076; I2 = 79.9%) (Figure S3).
Sensitivity analysis showed significant differences after the removal of each study. Egger’s test revealed no significant publication bias (p = 0.296).

3.3.3. Meta-Analysis of Adjusted ORs

Adjusted OR values in five studies were separately extracted for meta-analysis [24,25,28,29,33], and the results showed that children with vitamin D deficiency (four studies defined vitamin D deficiency as less than 20 ng/mL and one study defined it as less than 10 ng/mL) have a 2.35 times greater chance of developing UTI than those with vitamin D sufficiency (OR: 2.35; 95% CI: 1.82, 3.04; p < 0.001) with acceptable heterogeneity (p = 0.334; I2 = 12.5%) (Figure 6).
The results of subgroup analysis based on different regions showed a significant association between vitamin D deficiency and the likelihood of UTI in the studies conducted in Asia [24,33] (OR: 2.89, 95% CI: 1.55, 5.37; p = 0.001; I2 = 22.2%) and the Middle East (OR: 2.24, 95% CI: 1.59, 3.15; p < 0.001; I2 = 16.3%) (Figure S4).
Sensitivity analysis showed that the overall effect remained significant after removing each study.

4. Discussion

A meta-analysis of serum vitamin D levels found that children with UTI had lower serum vitamin D levels than healthy controls. A meta-analysis of ORs showed a significant association between low vitamin D levels and risk of UTI in children. Moreover, sensitivity analysis showed that this association was stable.
A previous systematic review and meta-analysis reported the association of serum vitamin D levels and UTI risk in children [37]. That review included six studies (UTI: 339, control: 306), whereas our review included 13 studies (UTI: 839, control: 929). Similar to our results, there was high heterogeneity among the included studies, and it was found that children with UTI had lower vitamin D levels than healthy controls. However, the earlier review found a potential publication bias, while the Egger’s test revealed no significant differences in our results. We found that the results were still statistically different when constructing trim-and-fill and sensitivity analyses. In addition, we conducted an analysis using ORs to evaluate the relationship between different vitamin D levels and the likelihood of UTI and found that there was a 5.49 times greater chance of children developing UTI when serum vitamin D levels were less than 20 ng/mL than for those with vitamin D sufficiency.
When subgroup analyses were conducted based on different regions, the results showed that in Asia, children with UTIs had lower vitamin D concentrations than healthy controls and that there was a significant association between low vitamin D levels and the risk of UTIs. However, this was not the case in Europe or the Middle East. Latitudes and regions can affect serum vitamin D levels because of sunlight exposure, which is the primary source of vitamin D for the human body. The farther away from the equator, the less sunlight a region receives, resulting in lower serum vitamin D levels for residents. However, serum vitamin D levels have been observed to be higher in northern Europe than in southern Europe, with this being the influence of diet and skin color [40,41]. In the two European studies conducted in Romania and Switzerland, local eating habits may have affected vitamin D levels. Additionally, the limited literature may not reflect the true effect value. Among studies conducted in the Middle East, one study found the opposite, showing that children with UTI had higher concentrations of vitamin D than healthy controls. When pregnant women have vitamin D deficiency, their babies also develop vitamin D deficiency. In the Middle East, women have extremely low levels of serum vitamin D due to skin-covering clothes and lack of sun exposure [42,43]. Furthermore, serum vitamin D levels show high variability among countries in the Middle East [40], which may be a factor in the Middle East subgroup analysis results that is inconsistent with the overall effect. Low vitamin D levels have been observed in Asian countries such as China, Mongolia, and India, while levels are higher in Japan and Malaysia [40,44,45,46,47]. The two studies in Asia included in our meta-analysis were conducted in China and India, and the subgroup results showed that children with UTI had lower serum vitamin D levels than controls, and a low vitamin D level was strongly associated with the likelihood of UTI. Subgroup analysis of the adjusted OR based on regions showed that children with vitamin D deficiency have a 2.89 times greater chance of developing UTI than healthy controls in Asia, compared with 2.35 times in the Middle East. This may be attributed to a variety of factors affecting UTI and not just serum vitamin D levels.
Two studies conducted a stratified analysis according to the sex of the children, and we conducted a meta-analysis of the ORs for boys and girls. The results showed a significant association between low vitamin D levels and the likelihood of UTI in female children, but not in male children. Due to the structure of the urinary tract, females are more likely to develop UTI than males, which may explain our results. However, as only two studies were included, our findings may not accurately reflect the real effects.
Subgroup analyses were also performed based on study quality and vitamin D measurement methods to identify the sources of heterogeneity. The heterogeneity did not decrease significantly. Moreover, through sensitivity analysis, we identified four studies that may be major contributors to heterogeneity [23,25,30,34]. This difference remained significant when the above four studies were excluded from the analysis. Overall, heterogeneity may be due to sex, age, ethnicity, continence, latitude, dietary habits, skin-covering clothes, cutoff value, and measurement methods for serum vitamin D.
Several points should be considered when interpreting the results of this systematic review and meta-analysis. First, the results showed that low vitamin D levels were associated with UTI; however, the included studies were case–control or cross-sectional studies, and vitamin D concentrations were measured after the children had acute UTIs, making it difficult to infer causality. Vitamin D deficiency is likely a consequence or cause of chronic inflammation. Some researchers believe that low 25(OH)D levels are not a cause, but a result of chronic inflammation [7]. However, only participants with non-recurrent UTI were included in this study. Further prospective studies are required to better explain this association. Importantly, for children with UTI, can vitamin D supplementation reduce the incidence of UTI? How vitamin D is supplemented and how much is taken is something we should be concerned about. Based on the guidelines, 400 IU of vitamin D per day was recommended for infants within 6 months, 400 to 600 IU/day for infants aged 6–12 months, and 600 IU/day for children aged 1–3 years [48]. For children older than 3 years, sunbathing was recommended, and vitamin D supplementation is not necessary [48]. Second, the studies only included Europe, Asia, and the Middle East, and the results may not be representative. Third, most studies matched season and age, while some adjusted for sex and age as confounding factors. However, other variables such as race, skin color, lifestyle, diet, and exposure to sunshine can affect vitamin D levels and may affect the overall effect values. Fourth, the cut-off values for vitamin D deficiency or insufficiency were inconsistent across studies. Most studies defined 25(OH) D levels less than 20 ng/mL as deficient, and more than 20 ng/mL and less than 30 ng/mL as insufficient [23,24,25,26,27,28,30,33,35,39]; other studies used other thresholds, which will affect the frequency of exposure. This may have been a source of heterogeneity. Finally, the meta-analysis revealed a significant heterogeneity. Although different subgroup analyses were conducted, the source of the heterogeneity could not be determined. However, sensitivity analyses showed robust results.

5. Conclusions

In conclusion, low serum vitamin D levels were associated with a higher risk of UTI, especially when vitamin D levels are below 20 ng/mL. Furthermore, Asian or female children with low serum vitamin D levels may be at a greater risk of developing UTI.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/nu15122690/s1, Figure S1: Subgroup analysis—forest plot of serum vitamin D levels in children with/without UTI. (A) Subgroup analysis based on children from different continents. (B) Subgroup analysis based on the quality of the included studies. (C) Subgroup analysis based on different measurement methods for serum vitamin D. Abbreviations: UTI, urinary tract infection. Figure S2: Subgroup analysis—forest plots of the likelihood of UTI in children based on sex. ORs were obtained from the frequency of exposure in the UTI and control groups. “Overall”: the result obtained regardless of sex. Exposure: low levels of serum vitamin D (including: insufficiency and deficiency). Abbreviations: UTI, urinary tract infection. Figure S3: Subgroup analysis—forest plots of the likelihood of UTI in children based on region. ORs were obtained from the frequency of exposure in the UTI and control groups. Exposure: low levels of serum vitamin D (including: insufficiency and deficiency). Abbreviations: UTI, urinary tract infection. Figure S4: Subgroup analysis—forest plots of adjusted ORs for the likelihood of UTI in children according to regions. Adjusted ORs were reported by five studies. Abbreviations: UTI, urinary tract infection; ORs, Odds Ratios.

Author Contributions

Conceptualization, D.M. and Y.G.; methodology, Y.G. and S.Y.; software, Y.G. and S.Y.; validation, S.Y.; formal analysis, Y.G. and S.Y.; investigation, Y.G. and J.Y.; resources, Y.G. and J.Y.; data curation, Y.G. and S.Y.; writing—original draft preparation, Y.G.; writing—review and editing, Y.G., S.Y. and J.Y.; visualization, Y.G. and D.M.; supervision, D.M. and J.Y.; project administration, D.M.; funding acquisition, D.M. and J.Y. All authors have read and agreed to the published version of the manuscript.

Funding

This work was supported by the National Natural Science Foundation of China (81971433, 82271749, 82201905); the National Key R&D Program of China (2021YFC2701700, 2021YFC2701704); grants from the Science and Technology Bureau of Sichuan Province (2022NSFSC1498); and Fundamental Research Funds for the Central University (SCU2022D006).

Institutional Review Board Statement

Not applicable.

Informed Consent Statement

Not applicable.

Data Availability Statement

All relevant data are within the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Zorc, J.J.; Levine, D.A.; Platt, S.L.; Dayan, P.S.; Macias, C.G.; Krief, W.; Schor, J.; Bank, D.; Shaw, K.N.; Kuppermann, N. Clinical and demographic factors associated with urinary tract infection in young febrile infants. Pediatrics 2005, 116, 644–648. [Google Scholar] [CrossRef] [Green Version]
  2. Mattoo, T.K.; Shaikh, N.; Nelson, C.P. Contemporary Management of Urinary Tract Infection in Children. Pediatrics 2021, 147, e2020012138. [Google Scholar] [CrossRef]
  3. Schlager, T.A. Urinary Tract Infections in Infants and Children. Microbiol. Spectr. 2016, 4, 4–5. [Google Scholar] [CrossRef]
  4. Shaikh, N.; Morone, N.E.; Lopez, J.; Chianese, J.; Sangvai, S.; D’Amico, F.; Hoberman, A.; Wald, E.R. Does this child have a urinary tract infection? JAMA 2007, 298, 2895–2904. [Google Scholar] [CrossRef]
  5. Stein, R.; Dogan, H.S.; Hoebeke, P.; Kočvara, R.; Nijman, R.J.; Radmayr, C.; Tekgül, S. Urinary tract infections in children: EAU/ESPU guidelines. Eur. Urol. 2015, 67, 546–558. [Google Scholar] [CrossRef]
  6. White, J.H. Vitamin D signaling, infectious diseases, and regulation of innate immunity. Infect. Immun. 2008, 76, 3837–3843. [Google Scholar] [CrossRef] [Green Version]
  7. Mangin, M.; Sinha, R.; Fincher, K. Inflammation and vitamin D: The infection connection. Inflamm. Res. 2014, 63, 803–819. [Google Scholar] [CrossRef] [Green Version]
  8. Fletcher, J.; Bishop, E.L.; Harrison, S.R.; Swift, A.; Cooper, S.C.; Dimeloe, S.K.; Raza, K.; Hewison, M. Autoimmune disease and interconnections with vitamin D. Endocr. Connect. 2022, 11, e210554. [Google Scholar] [CrossRef]
  9. Kamen, D.L.; Tangpricha, V. Vitamin D and molecular actions on the immune. system: Modulation of innate and autoimmunity. J. Mol. Med. 2010, 88, 441–450. [Google Scholar] [CrossRef] [Green Version]
  10. Deluca, H.F.; Cantorna, M.T. Vitamin D: Its role and uses in immunology. FASEB J. 2001, 15, 2579–2585. [Google Scholar] [CrossRef] [Green Version]
  11. Ganmaa, D.; Enkhmaa, D.; Nasantogtokh, E.; Sukhbaatar, S.; Tumur-Ochir, K.E.; Manson, J.E. Vitamin D, respiratory infections, and chronic disease: Review of meta-analyses and randomized clinical trials. J. Intern. Med. 2022, 291, 141–164. [Google Scholar] [CrossRef]
  12. Islam, M.A.; Khandker, S.S.; Alam, S.S.; Kotyla, P.; Hassan, R. Vitamin D status in patients with systemic lupus erythematosus (SLE): A systematic review and meta-analysis. Autoimmun. Rev. 2019, 18, 102392. [Google Scholar] [CrossRef]
  13. Székely, J.I.; Pataki, Á. Effects of vitamin D on immune disorders with special. regard to asthma, COPD and autoimmune diseases: A short review. Expert Rev. Respir. Med. 2012, 6, 683–704. [Google Scholar] [CrossRef]
  14. Adams, J.S.; Hewison, M. Update in vitamin D. J. Clin. Endocrinol. Metab. 2010, 95, 471–478. [Google Scholar] [CrossRef] [Green Version]
  15. Nnoaham, K.E.; Clarke, A. Low serum vitamin D levels and tuberculosis: A systematic review and meta-analysis. Int. J. Epidemiol. 2008, 37, 113–119. [Google Scholar] [CrossRef] [PubMed]
  16. Laaksi, I.; Ruohola, J.P.; Tuohimaa, P.; Auvinen, A.; Haataja, R.; Pihlajamäki, H.; Ylikomi, T. An association of serum vitamin D concentrations < 40 nmol/L with acute respiratory tract infection in young Finnish men. Am. J. Clin. Nutr. 2007, 86, 714–717. [Google Scholar]
  17. Schwalfenberg, G.K. A review of the critical role of vitamin D in the functioning. of the immune system and the clinical implications of vitamin D deficiency. Mol. Nutr. Food Res. 2011, 55, 96–108. [Google Scholar] [CrossRef]
  18. Science, M.; Maguire, J.L.; Russell, M.L.; Smieja, M.; Walter, S.D.; Loeb, M. Low serum 25-hydroxyvitamin D level and risk of upper respiratory tract infection in children and adolescents. Clin. Infect. Dis. 2013, 57, 392–397. [Google Scholar] [CrossRef] [Green Version]
  19. Shah, K.; Varna, V.P.; Pandya, A.; Saxena, D. Low vitamin D levels and prognosis in a COVID-19 pediatric population: A systematic review. QJM 2021, 114, 447–453. [Google Scholar] [CrossRef]
  20. di Filippo, L.; Uygur, M.; Locatelli, M.; Nannipieri, F.; Frara, S.; Giustina, A. Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization. Endocrine 2023, 80, 669–683. [Google Scholar] [CrossRef]
  21. Hertting, O.; Holm, Å.; Lüthje, P.; Brauner, H.; Dyrdak, R.; Jonasson, A.F.; Wiklund, P.; Chromek, M.; Brauner, A. Vitamin D induction of the human antimicrobial Peptide cathelicidin in the urinary bladder. PLoS ONE 2010, 5, e15580. [Google Scholar] [CrossRef] [Green Version]
  22. Övünç Hacıhamdioğlu, D.; Altun, D.; Hacıhamdioğlu, B.; Çekmez, F.; Aydemir, G.; Kul, M.; Müftüoğlu, T.; Süleymanoğlu, S.; Karademir, F. The Association between Serum 25-Hydroxy Vitamin D Level and Urine Cathelicidin in Children with a Urinary Tract Infection. J. Clin. Res. Pediatr. Endocrinol. 2016, 8, 325–329. [Google Scholar] [CrossRef] [PubMed]
  23. Mahyar, A.; Ayazi, P.; Safari, S.; Dalirani, R.; Javadi, A.; Esmaeily, S. Association between vitamin D and urinary tract infection in children. Korean J. Pediatr. 2018, 61, 90–94. [Google Scholar] [CrossRef] [Green Version]
  24. Chidambaram, S.; Pasupathy, U.; Geminiganesan, S.; R, D. The Association Between Vitamin D and Urinary Tract Infection in Children: A Case-Control Study. Cureus 2022, 14, e25291. [Google Scholar] [CrossRef]
  25. Tekin, M.; Konca, C.; Celik, V.; Almis, H.; Kahramaner, Z.; Erdemir, A.; Gulyuz, A.; Uckardes, F.; Turgut, M. The Association between Vitamin D Levels and Urinary Tract Infection in Children. Horm. Res. Paediatr. 2015, 83, 198–203. [Google Scholar] [CrossRef]
  26. Georgieva, V.; Kamolvit, W.; Herthelius, M.; Lüthje, P.; Brauner, A.; Chromek, M. Association between vitamin D, antimicrobial peptides and urinary tract infection in infants and young children. Acta Paediatr. 2019, 108, 551–556. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Mahmoudzadeh, H.; Nikibakhsh, A.A.; Pashapour, S.; Ghasemnejad-Berenji, M. Relationship between low serum vitamin D status and urinary tract infection in children: A case-control study. Paediatr. Int. Child Health 2020, 40, 181–185. [Google Scholar] [CrossRef] [PubMed]
  28. Sadeghzadeh, M.; Khoshnevisasl, P.; Motamed, N.; Faghfouri, L. The serum vitamin D levels in children with urinary tract infection: A case-control study. New Microbes New Infect. 2021, 43, 100911. [Google Scholar] [CrossRef]
  29. Shalaby, S.A.; Handoka, N.M.; Amin, R.E. Vitamin D deficiency is associated with urinary tract infection in children. Arch. Med. Sci. 2018, 14, 115–121. [Google Scholar] [CrossRef]
  30. Muntean, C.; Săsăran, M. Vitamin D Status and Its Role in First-Time and Recurrent Urinary Tract Infections in Children: A Case-Control Study. Children 2021, 8, 419. [Google Scholar] [CrossRef]
  31. Raza, M.; Jabeen, N.; Najam, M.; Tareen, R.; Intekhab, A.; Uz Zaman Shahzad, Q.; Hamza, M. Determine the Mean Levels of Vitamin D in Children with First Episode of Urinary Tract Infection. Pak. J. Med. Health Sci. 2022, 16, 733–735. [Google Scholar] [CrossRef]
  32. Qadir, S.; Memon, S.; Chohan, M.N.; Memon, Y. Frequency of Vitamin-D deficiency in children with Urinary tract infection: A descriptive cross-sectional study. Pak. J. Med. Sci. 2021, 37, 1058–1062. [Google Scholar] [CrossRef]
  33. Yang, J.; Chen, G.; Wang, D.; Chen, M.; Xing, C.; Wang, B. Low serum. 25-hydroxyvitamin D level and risk of urinary tract infection in infants. Medicine 2016, 95, e4137. [Google Scholar] [CrossRef]
  34. Sherkatolabbasieh, H.; Firouzi, M.; Shafizadeh, S.; Nekohid, M. Evaluation of. the relationship between vitamin D levels and prevalence of urinary tract infections in children. New Microbes New Infect. 2020, 37, 100728. [Google Scholar] [CrossRef]
  35. Noorbakhsh, S.; Nia, S.J.; Movahedi, Z.; Ashouri, S. Does the trace element deficiency (vit A, D & zinc) have any role in vulnerability to urinary tract infection in children: A case-control study: Tehran, Iran. Open Urol. Nephrol. J. 2019, 12, 23–26. [Google Scholar]
  36. Katikaneni, R.; Ponnapakkam, T.; Ponnapakkam, A.; Gensure, R. Breastfeeding does not protect against urinary tract infection in the first 3 months of life, but vitamin D supplementation increases the risk by 76%. Clin. Pediatr. 2009, 48, 750–755. [Google Scholar] [CrossRef]
  37. Li, X.; Yu, Q.; Qin, F.; Zhang, B.; Lu, Y. Serum Vitamin D Level and the Risk of Urinary Tract Infection in Children: A Systematic Review and Meta-Analysis. Front. Public Health 2021, 9, 637529. [Google Scholar] [CrossRef]
  38. Lips, P.; Cashman, K.D.; Lamberg-Allardt, C.; Bischoff-Ferrari, H.A.; Obermayer-Pietsch, B.; Bianchi, M.L.; Stepan, J.; El-Hajj Fuleihan, G.; Bouillon, R. Current vitamin D status in European and Middle East countries and strategies to prevent vitamin D deficiency: A position statement of the European Calcified Tissue Society. Eur. J. Endocrinol. 2019, 180, 23–54. [Google Scholar] [CrossRef] [Green Version]
  39. Bekdas, M.; Caliskan, B.; Karabork, S.; Acar, S.; Kabakus, N. Do low vitamin D levels facilitae renal parenchymal injury? Paediatr. Indones. 2020, 60, 205–211. [Google Scholar] [CrossRef]
  40. van Schoor, N.M.; Lips, P. Worldwide vitamin D status. Best Pract. Res. Clin. Endocrinol. Metab. 2011, 25, 671–680. [Google Scholar] [CrossRef]
  41. Öhlund, I.; Silfverdal, S.A.; Hernell, O.; Lind, T. Serum 25-hydroxyvitamin D levels in preschool-age children in northern Sweden are inadequate after summer and diminish further during winter. J. Pediatr. Gastroenterol. Nutr. 2013, 56, 551–555. [Google Scholar] [CrossRef] [PubMed]
  42. Lips, P. Worldwide status of vitamin D nutrition. J. Steroid. Biochem. Mol. Biol. 2010, 121, 297–300. [Google Scholar] [CrossRef] [PubMed]
  43. Lips, P. Vitamin D status and nutrition in Europe and Asia. J. Steroid Biochem. Mol. Biol. 2007, 103, 620–625. [Google Scholar] [CrossRef]
  44. Bater, J.; Bromage, S.; Jambal, T.; Tsendjav, E.; Lkhagvasuren, E.; Jutmann, Y.; Martineau, A.R.; Ganmaa, D. Prevalence and Determinants of Vitamin D Deficiency in 9595 Mongolian Schoolchildren: A Cross-Sectional Study. Nutrients 2021, 13, 4175. [Google Scholar] [CrossRef]
  45. Chen, Z.; Lv, X.; Hu, W.; Qian, X.; Wu, T.; Zhu, Y. Vitamin D Status and. Its Influence on the Health of Preschool Children in Hangzhou. Front. Public Health 2021, 9, 675403. [Google Scholar] [CrossRef]
  46. Wang, L.L.; Wang, H.Y.; Wen, H.K.; Tao, H.Q.; Zhao, X.W. Vitamin D status among infants, children, and adolescents in southeastern China. J. Zhejiang Univ. Sci. B 2016, 17, 545–552. [Google Scholar] [CrossRef] [Green Version]
  47. Oktaria, V.; Putri, D.A.D.; Ihyauddin, Z.; Julia, M.; Sulistyoningrum, D.C.; Koon, P.B.; Danchin, M.; Murni, I.K. Vitamin D deficiency in South-East Asian children: A systematic review. Arch. Dis. Child 2022, 107, 980–987. [Google Scholar] [CrossRef]
  48. Płudowski, P.; Kos-Kudła, B.; Walczak, M.; Fal, A.; Zozulińska-Ziółkiewicz, D.; Sieroszewski, P.; Peregud-Pogorzelski, J.; Lauterbach, R.; Targowski, T.; Lewiński, A.; et al. Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland. Nutrients 2023, 15, 695. [Google Scholar] [CrossRef]
Figure 1. PRISMA search flowchart and studies included in the systematic review and meta-analysis.
Figure 1. PRISMA search flowchart and studies included in the systematic review and meta-analysis.
Nutrients 15 02690 g001
Figure 2. Forest plot showing the WMD in serum vitamin D levels between children with UTI and controls. The results illustrated that vitamin D levels in children with UTI were on average 7.73 ng/mL lower than those in the controls. Abbreviations: UTI, urinary tract infection; WMD, weighted mean difference [22,23,24,25,26,29,30,33,34,35,39].
Figure 2. Forest plot showing the WMD in serum vitamin D levels between children with UTI and controls. The results illustrated that vitamin D levels in children with UTI were on average 7.73 ng/mL lower than those in the controls. Abbreviations: UTI, urinary tract infection; WMD, weighted mean difference [22,23,24,25,26,29,30,33,34,35,39].
Nutrients 15 02690 g002
Figure 3. Funnel plot after trim-and-fill method in serum vitamin D levels between children with UTI and controls. Abbreviations: UTI, urinary tract infection. The circle indicates the outcome of each included study, while the square indicates the imputed studies so as to generate symmetrical funnel plots.
Figure 3. Funnel plot after trim-and-fill method in serum vitamin D levels between children with UTI and controls. Abbreviations: UTI, urinary tract infection. The circle indicates the outcome of each included study, while the square indicates the imputed studies so as to generate symmetrical funnel plots.
Nutrients 15 02690 g003
Figure 4. Forest plots illustrating the association between serum vitamin D levels and UTI in children. ORs were calculated from the frequency of exposure in the UTI and control groups. Exposure means low levels of serum vitamin D levels (including: insufficiency and deficiency). Abbreviations: UTI, urinary tract infection; ORs, Odds Ratios [22,23,24,27,28,29,30,33,34].
Figure 4. Forest plots illustrating the association between serum vitamin D levels and UTI in children. ORs were calculated from the frequency of exposure in the UTI and control groups. Exposure means low levels of serum vitamin D levels (including: insufficiency and deficiency). Abbreviations: UTI, urinary tract infection; ORs, Odds Ratios [22,23,24,27,28,29,30,33,34].
Nutrients 15 02690 g004
Figure 5. Subgroup analysis—forest plots of likelihood of UTI in children based on vitamin D levels. ORs were obtained from the frequency of vitamin D levels less than 20 ng/mL, between 20 and 30 ng/mL, and more than 30 ng/mL. Abbreviation: UTI, urinary tract infection [23,24,27,30,33].
Figure 5. Subgroup analysis—forest plots of likelihood of UTI in children based on vitamin D levels. ORs were obtained from the frequency of vitamin D levels less than 20 ng/mL, between 20 and 30 ng/mL, and more than 30 ng/mL. Abbreviation: UTI, urinary tract infection [23,24,27,30,33].
Nutrients 15 02690 g005
Figure 6. Forest plots illustrating the association between serum vitamin D levels and UTI in children. Adjusted ORs were reported by five studies. Abbreviations: UTI, urinary tract infection; ORs, Odds Ratios [24,25,28,29,33].
Figure 6. Forest plots illustrating the association between serum vitamin D levels and UTI in children. Adjusted ORs were reported by five studies. Abbreviations: UTI, urinary tract infection; ORs, Odds Ratios [24,25,28,29,33].
Nutrients 15 02690 g006
Table 1. Characteristics of the 13 included studies.
Table 1. Characteristics of the 13 included studies.
StudyStudy
Design
CountryTotal Number Cases/ControlsAgeVitamin D
(ng/mL)
Exposure Number
Cases/
Controls
Estimated OR (95% CI)Newcastle
-Ottawa
Score
UTIControl
Chidambaram
2022 [24]
case–controlSouth India82/82UTI: 2.36 ± 1.42 y
control: 2.57 ± 1.26 y
24.27 ± 9.7031.97 ± 10.760/42Adjusted
OR: 2.486
(1.610, 3.838)
8
Sadeghzadeh
2021 [28]
case–controlIran40/401–12 y__30/19Adjusted
OR: 2.884
(1.075, 7.738)
7
Muntean
2021 [30]
case–controlRomania59/42UTI: 3.95 ± 2.94 y
control: 3.25 ± 3.03 y
26.06 ± 14.2552.99 ± 23.1641/6_7
Sherkatolabbasieh
2020 [34]
case–controlIran44/214UTI: 6.58 ± 1.57 y
control: 6.7 ± 1.58 y
29.2 ± 12.2732.04 ± 15.0425/113_8
Mahmoudzadeh
2020 [27]
case–controlIran75/75UTI: 6.9 ± 4.2 y
control: 7.9 ± 3.8 y
__68/48_7
Bekdas
2020 [39]
case–controlTurkey43/24UTI: 6.9 ± 4.2 y
control: 7.9 ± 3.8 y
18 ± 923 ± 10.6__6
Noorbakhsh
2019 [35]
case–controlIran25/40mean: 2.7 y45.7 ± 21.0545.9 ± 24.8__7
Georgieva
2019 [26]
cross-sectionSweden76/444.5–33.5 m32.32 ± 8.4840.44 ± 13.2__5
Mahyar
2018 [23]
case–controlIran70/70UTI: 53.2 ± 35.6 m
control: 62.2 ± 36.1 m
20.4 ± 8.616.9 ± 7.457/67_8
Shalaby
2018 [29]
case–controlEgypt50/50UTI: 0.98 ± 1.15 y
control: 0.90 ± 1.23 y
4.2 ± 1.0810.36 ± 2.2419/6Adjusted
OR: 1.94
(1.61, 2.82)
7
Övünç
2016 [22]
case–controlTurkey36/38UTI: 6.8 ± 3.6 y
control: 6.3 ± 2.8 y
16.5 ± 6.323.7 ± 1128/17_7
Yang
2016 [33]
case–controlChina132/106UTI: 7.29 ± 3.06 m
control: 7.09 ± 3.25 m
29.09 ± 9.5638.59 ± 12.4174/33Adjusted
OR: 5.619
(1.469, 21.484)
7
Tekin
2015 [25]
case–controlTurkey82/64UTI: 2.57 ± 2.56 y
control: 2.10 ± 1.37 y
11.7 ± 3.327.6 ± 4.7_Adjusted
OR: 3.503
(1.621, 7.571)
8
Exposure: low levels of serum vitamin D (including: insufficiency and deficiency); Mean ± SD (all such values); UTI: urinary tract infection.
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Gan, Y.; You, S.; Ying, J.; Mu, D. The Association between Serum Vitamin D Levels and Urinary Tract Infection Risk in Children: A Systematic Review and Meta-Analysis. Nutrients 2023, 15, 2690. https://doi.org/10.3390/nu15122690

AMA Style

Gan Y, You S, Ying J, Mu D. The Association between Serum Vitamin D Levels and Urinary Tract Infection Risk in Children: A Systematic Review and Meta-Analysis. Nutrients. 2023; 15(12):2690. https://doi.org/10.3390/nu15122690

Chicago/Turabian Style

Gan, Yan, Siyi You, Junjie Ying, and Dezhi Mu. 2023. "The Association between Serum Vitamin D Levels and Urinary Tract Infection Risk in Children: A Systematic Review and Meta-Analysis" Nutrients 15, no. 12: 2690. https://doi.org/10.3390/nu15122690

APA Style

Gan, Y., You, S., Ying, J., & Mu, D. (2023). The Association between Serum Vitamin D Levels and Urinary Tract Infection Risk in Children: A Systematic Review and Meta-Analysis. Nutrients, 15(12), 2690. https://doi.org/10.3390/nu15122690

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop